Home Nucleus Medical Devices U.K. Pharmacogenetic Testing Market to 2032

U.K. Pharmacogenetic Testing Market to 2032

Overview

The U.K. Pharmacogenetic Testing Market is expected to reach a 487.80 USD Million by 2032 and is projected to grow at a CAGR of 11.10% from 2025 to 2032.

Revenue, 2024 (USD Million)
265.24
Forecast, 2032 (USD Million)
487.80
CAGR, 2024 - 2032
11.10%
Report Coverage
U.K.

U.K. Pharmacogenetic Testing Market 2018-2032 USD Million

U.K. Pharmacogenetic Testing Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 265.24 USD Million
  • Projected Market Size (2032): 487.80 USD Million
  • CAGR (2025-2032): 11.10%

Key Findings of U.K. Pharmacogenetic Testing Market

  • The U.K. Pharmacogenetic Testing Market was valued at 265.24 USD Million in 2024.
  • The U.K. Pharmacogenetic Testing Market is likely to grow at a CAGR of 11.10% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Blood in Sample Segment accounted for the largest share of the market with a revenue of 143.36 USD Million
  • The fastest growing segment CYP2C19 in Gene Segment grew Fastest with a CAGR of 15.83% during the forecast period from 2024 to 2032.

U.K. Pharmacogenetic Testing Market Scope

U.K. Pharmacogenetic Testing Market Segmentation & Scope
Application
  • Drug Regulation
  • Drug Development
  • Clinical Practice
Therapeutic Area
  • Others
  • Neurology
  • Oncology
  • Gynecology
  • Dermatology
  • Immunology & Hypersensitivity
  • Endocrinology
  • Genomics
  • Anesthesiology
  • Gastroenterology
  • Cardiology
Distribution Channel
  • Direct-to-Customer Services
  • Mail-Order Pharmacies
  • Retail Pharmacies
  • Hospital Pharmacy
End User
  • Others
  • Research Centres and Academic Institutes
  • Pharmaceutical & Biotechnology Companies
  • Healthcare Providers
Sample
  • Saliva
  • Blood
Gene
  • Others
  • TMPT
  • HTR2A/C
  • SLC6A4
  • D4D4
  • DRD3
  • ONCOTYPE DX® AND MAMMAPRINT®
  • OPRM1
  • CYP2D
  • HLA-B*5701
  • HLA-B*1502
  • CYP1A2
  • CYP2C9 AND VKORC1
  • CYP2D6
  • CYP2C19
Type
  • Single Gene Tests
  • Array-Based Tests
  • Whole Exome Sequencing
  • Whole Genome Sequencing
Drug
  • Over-the-Counter Medications
  • Vitamins
  • Herbal Supplements
  • Recreational Drugs
  • Nutraceuticals
  • Prescription Drugs

U.K. Pharmacogenetic Testing Market Data Coverage Insights

Study Period 2024-2032
Base Year 2021
Unit Revenue in USD Million
Market Value in 2024 265.24 USD Million
Market Value in 2032 487.80 USD Million
CAGR (2025-2032) 11.10%
Historic Data 2016-2023
Market Segments Covered Application,Therapeutic Area,Distribution Channel,End User,Sample,Gene,Type,Drug

Regional Insights:

  • Leading Market (2024-2032): U.K., leading in terms of revenue 265.24 USD Million in 2024
    • Key Country: U.K., leading in terms of revenue with value of 265.24 USD Million in 2024.

Segments and Scope

  • U.K. Pharmacogenetic Testing Market to 2032, By Application
    • Clinical Practice is the largest segment in U.K. Pharmacogenetic Testing Market to 2032 with a revenue of 117.66 USD Million in the year 2024.
    • Clinical Practice is the Fastest growing segment in U.K. Pharmacogenetic Testing Market to 2032 with a Growth rate of 11.65 % in forecast period 2025-2032.
  • U.K. Pharmacogenetic Testing Market to 2032, By Therapeutic Area
    • Cardiology is the largest segment in U.K. Pharmacogenetic Testing Market to 2032 with a revenue of 47.70 USD Million in the year 2024.
    • Cardiology is the Fastest growing segment in U.K. Pharmacogenetic Testing Market to 2032 with a Growth rate of 15.07 % in forecast period 2025-2032.
  • U.K. Pharmacogenetic Testing Market to 2032, By Distribution Channel
    • Hospital Pharmacy is the largest segment in U.K. Pharmacogenetic Testing Market to 2032 with a revenue of 118.00 USD Million in the year 2024.
    • Hospital Pharmacy is the Fastest growing segment in U.K. Pharmacogenetic Testing Market to 2032 with a Growth rate of 11.74 % in forecast period 2025-2032.
  • U.K. Pharmacogenetic Testing Market to 2032, By End User
    • Healthcare Providers is the largest segment in U.K. Pharmacogenetic Testing Market to 2032 with a revenue of 104.66 USD Million in the year 2024.
    • Healthcare Providers is the Fastest growing segment in U.K. Pharmacogenetic Testing Market to 2032 with a Growth rate of 11.91 % in forecast period 2025-2032.
  • U.K. Pharmacogenetic Testing Market to 2032, By Sample
    • Blood is the largest segment in U.K. Pharmacogenetic Testing Market to 2032 with a revenue of 143.36 USD Million in the year 2024.
    • Blood is the Fastest growing segment in U.K. Pharmacogenetic Testing Market to 2032 with a Growth rate of 11.30 % in forecast period 2025-2032.
  • U.K. Pharmacogenetic Testing Market to 2032, By Gene
    • CYP2C19 is the largest segment in U.K. Pharmacogenetic Testing Market to 2032 with a revenue of 37.59 USD Million in the year 2024.
    • CYP2C19 is the Fastest growing segment in U.K. Pharmacogenetic Testing Market to 2032 with a Growth rate of 15.83 % in forecast period 2025-2032.
  • U.K. Pharmacogenetic Testing Market to 2032, By Type
    • Whole Genome Sequencing is the largest segment in U.K. Pharmacogenetic Testing Market to 2032 with a revenue of 124.91 USD Million in the year 2024.
    • Whole Genome Sequencing is the Fastest growing segment in U.K. Pharmacogenetic Testing Market to 2032 with a Growth rate of 11.71 % in forecast period 2025-2032.
  • U.K. Pharmacogenetic Testing Market to 2032, By Drug
    • Prescription Drugs is the largest segment in U.K. Pharmacogenetic Testing Market to 2032 with a revenue of 80.04 USD Million in the year 2024.
    • Prescription Drugs is the Fastest growing segment in U.K. Pharmacogenetic Testing Market to 2032 with a Growth rate of 12.48 % in forecast period 2025-2032.

U.K. Pharmacogenetic Testing Market Company Share Analysis

 
Company Name Company Share Analysis
Illumina, Inc.
Thermo Fisher Scientific Inc.
QIAGEN
Sonic Healthcare Limited
BGI
U.K. Pharmacogenetic Testing Market Company Share Analysis

U.K. Pharmacogenetic Testing Market Geographical Sales Distribution, 2018-2032 USD Million

U.K. Pharmacogenetic Testing Market Geographical Sales Distribution, 2018-2032 USD Million

U.K. Pharmacogenetic Testing Market Company Profiling

U.K. Pharmacogenetic Testing Market Company Profiling

Industry Related Reports

South America Hospital Furniture Market
Middle East & Africa Hospital Furniture Market
North America Hospital Furniture Market
Europe Hospital Furniture Market
Asia-Pacific Hospital Furniture Market
Argentina Hospital Furniture Market
Australia Hospital Furniture Market
Belgium Hospital Furniture Market
Brazil Hospital Furniture Market
Canada Hospital Furniture Market
Frequently Asked Questions
The U.K. Pharmacogenetic Testing Market is segmented based on Segmentation Application,Therapeutic Area,Distribution Channel,End User,Sample,Gene,Type,Drug.
U.K. Pharmacogenetic Testing Market was valued at USD 265.24(Revenue in USD Million) in 2021.
U.K. Pharmacogenetic Testing Market is projected to grow at a CAGR of 11.10% during the forecast period of 2024 to 2032.
The Blood segment is expected to dominate the U.K. Pharmacogenetic Testing Market, holding a largest market share of 143.36 USD Million in 2024

U.K. Pharmacogenetic Testing Market Scope

U.K. Pharmacogenetic Testing Market Segmentation & Scope
Application
  • Drug Regulation
  • Drug Development
  • Clinical Practice
Therapeutic Area
  • Others
  • Neurology
  • Oncology
  • Gynecology
  • Dermatology
  • Immunology & Hypersensitivity
  • Endocrinology
  • Genomics
  • Anesthesiology
  • Gastroenterology
  • Cardiology
Distribution Channel
  • Direct-to-Customer Services
  • Mail-Order Pharmacies
  • Retail Pharmacies
  • Hospital Pharmacy
End User
  • Others
  • Research Centres and Academic Institutes
  • Pharmaceutical & Biotechnology Companies
  • Healthcare Providers
Sample
  • Saliva
  • Blood
Gene
  • Others
  • TMPT
  • HTR2A/C
  • SLC6A4
  • D4D4
  • DRD3
  • ONCOTYPE DX® AND MAMMAPRINT®
  • OPRM1
  • CYP2D
  • HLA-B*5701
  • HLA-B*1502
  • CYP1A2
  • CYP2C9 AND VKORC1
  • CYP2D6
  • CYP2C19
Type
  • Single Gene Tests
  • Array-Based Tests
  • Whole Exome Sequencing
  • Whole Genome Sequencing
Drug
  • Over-the-Counter Medications
  • Vitamins
  • Herbal Supplements
  • Recreational Drugs
  • Nutraceuticals
  • Prescription Drugs
Frequently Asked Questions
The U.K. Pharmacogenetic Testing Market is segmented based on Segmentation Application,Therapeutic Area,Distribution Channel,End User,Sample,Gene,Type,Drug.
U.K. Pharmacogenetic Testing Market was valued at USD 265.24(Revenue in USD Million) in 2021.
U.K. Pharmacogenetic Testing Market is projected to grow at a CAGR of 11.10% during the forecast period of 2024 to 2032.
The estimated market value of the U.K. Pharmacogenetic Testing Market for final year is USD 487.80 (USD Million).

U.K. Pharmacogenetic Testing Market Company Profiling

U.K. Pharmacogenetic Testing Market Company Profiling
Frequently Asked Questions
The U.K. Pharmacogenetic Testing Market is segmented based on Segmentation Application,Therapeutic Area,Distribution Channel,End User,Sample,Gene,Type,Drug.
U.K. Pharmacogenetic Testing Market was valued at USD 265.24(Revenue in USD Million) in 2021.
U.K. Pharmacogenetic Testing Market is projected to grow at a CAGR of 11.10% during the forecast period of 2024 to 2032.
The estimated market value of the U.K. Pharmacogenetic Testing Market for final year is USD 487.80 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES